← All medicines
Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension
Licence PA1543/002/001 · Marketed
- Licence holder
- Glenmark Pharmaceuticals s.r.o. (all products →)
- Active substances
- Mometasone furoate, Olopatadine
- Dosage form
- Nasal spray, suspension
- Route of administration
- Nasal use
- ATC code
- R01AD59
- First authorised
- 16/07/2021
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Fixed combination application (Article 10b of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.